No Q2 call yet for a Col­orado medtech; San Diego biotech col­labs with MD An­der­son

A Lit­tle­ton, CO, sleep ap­nea medtech was sup­posed to hold its Q2 earn­ings call on Aug. 15, then Aug. 22 and now maybe not for weeks.

It could take “sev­er­al weeks” be­fore Vivos Ther­a­peu­tics re­solves is­sues with a “tech­ni­cal reeval­u­a­tion of our rev­enue recog­ni­tion pol­i­cy,” the com­pa­ny said Mon­day af­ter the clos­ing bell. Vivos CEO Kirk Hunts­man said the de­lay is “un­re­lat­ed to the over­all health” of the com­pa­ny.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.